⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21797 | 0.44 | — | — | |
| SCHEMBL29889134 | 0.38 | — | — | |
| SCHEMBL29727296 | 0.38 | — | — | |
| SCHEMBL6559802 | 0.38 | — | — | |
| SCHEMBL7997385 | 0.38 | — | — | |
| Hydrogen Sulfide SCHEMBL15941638 | 0.38 | — | — | |
| Lithium SCHEMBL31213434 | 0.38 | — | — | |
| Methane SCHEMBL28458434 | 0.38 | — | — | |
| Water SCHEMBL490048 | 0.27 | — | — | |
| SCHEMBL74539 | 0.27 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117241823-A | Genetically modified human cell lines and uses thereof | 西吉隆医疗股份有限公司 | 2023-12-15 | — | — | CN | disclosed |
| CN-117136182-A | Cationic lipids based on \"God\" buffers | 翻译生物公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-117042723-A | Compositions, devices and methods for inducing antigen-specific immune tolerance | 西吉隆医疗股份有限公司 | 2023-11-10 | — | — | CN | disclosed |
| CN-116981473-A | Compositions, devices and methods for treating immune-mediated inflammatory diseases | 西吉隆医疗股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116964201-A | Compositions, devices and methods for treating MPS VI diseases | 西吉隆医疗股份有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-115915941-A | Pyridine (thio) amides as fungicidal compounds | 拜耳公司 | 2023-04-04 | — | — | CN | disclosed |
| CN-115803317-A | Azabicyclo (thio) amides as fungicidal compounds | 拜耳作物科学股份公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-115209920-A | Thienoazepine immunoconjugates and uses thereof | 博尔特生物治疗药物有限公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-106604927-B | Cytotoxic benzodiazepine derivatives | 伊缪诺金公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-114828894-A | Polymer-supported thienoazepine compounds and uses thereof | 博尔特生物治疗药物有限公司 | 2022-07-29 | — | — | CN | disclosed |
| US-20020103211-A1 | TRICYCLIC FUSED XANTHINE COMPOUNDS AND THEIR USES | CELL THERAPEUTICS, INC. | 2002-08-01 | — | — | US | disclosed |
| US-20020028823-A1 | THERAPEUTIC COMPOUNDS FOR INHIBITING INTERLEUKIN-12 SIGNALING AND METHODS FOR USING SAME | CELL THERAPEUTICS, INC. | 2002-03-07 | — | — | US | disclosed |
| EP-1171442-A1 | XANTHINE DERIVATIVES AND ANALOGS AS CELL SIGNALLING INHIBITORS | CELL THERAPEUTICS, INC. (US) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000061583-A1 | XANTHINE DERIVATIVES AND ANALOGS AS CELL SIGNALING INHIBITORS | CELL THERAPEUTICS, INC. (US) | 2000-10-19 | — | — | WO | disclosed |
| US-5824677-A | SUBSTITUTED WITH HETEROCYCLIC RING, ANTIINFLAMMATORY, IMMUNOSUPPRESSIVE | CELL THERAPEUTICS, INC. (US) | 1998-10-20 | — | — | US | disclosed |
| US-5777117-A | ANTIINFLAMMATORY, IMMUNOSUPPRESSIVE, CYTOTOXIC AGENTS; MICROBIOCIDES, FUNGICIDES | CELL THERAPEUTICS, INC. (US) | 1998-07-07 | — | — | US | disclosed |
| US-5750575-A | ANTIINFLAMMATORY AGENTS; IMMUNOSUPPRESSANTS; CYTOTOXIC AGENTS; MICROBIOCIDES; FUNGICIDES | CELL THERAPEUTICS, INC. (US) | 1998-05-12 | — | — | US | disclosed |
| US-5670507-A | Method for reversing multiple drug resistant phenotype | CELL THERAPEUTICS, INC. (US) | 1997-09-23 | — | — | US | disclosed |
| US-5641783-A | ANTIINFLAMMATORY OR IMMUNOSUPPRESSIVE AGENTS | CELL THERAPEUTICS, INC. (US) | 1997-06-24 | — | — | US | disclosed |
| WO-1995013808-A1 | METHOD FOR SELECTIVELY INHIBITING IL-2 SIGNAL TRANSDUCTION | CELL THERAPEUTICS, INC. (US) | 1995-05-26 | — | — | WO | disclosed |